Wisconsin Endocrine Society Meeting 2015

Wauwatosa, WI US
September 17, 2015

Address both hypoparathyroidism, both surgical and non-surgical. Since more extensive surgery has become more common for thyroid carcinoma, the frequency of post-surgical hypoparathyroidism has increased.  These patients can be very difficult to treat.  The FDA has recently approved parathyroid hormone (Natpara) for treatment. There is a knowledge gap in understanding when to use this treatment as compared to conventional treatment with vitamin D analogs.  Understand the risks of recommending and practice patterns of central neck dissections for thyroid carcinoma with respect to hypoparathyroidism.  Recognize the difficulty in treating this problem.  Reduce the knowledge gap with respect to appreciating the risks of hyperparathyroidism and treatment options.  


Target Audience

Physician Assistants
Nurse Practioners

Learning Objectives

  • Describe the epidemiology and differential diagnosis of hypoparathyroidism
  • Recognize biochemical changes that conform hypoparathyroidism
  • Summarize medical management options for hypoparathyroidism
Additional information


Ginny Wiatrowski
Phone Number: 
+1 (414) 777-7661
Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 1.00 Hours of Participation
    Hours of Participation credit.
Course opens: 
Course expires: 
Event starts: 
09/17/2015 - 12:00am CDT
Event ends: 
09/17/2015 - 12:00am CDT
McCormick & Schmick's Steak & Seafood Restaurant
2550 N. Mayfair Rd.
Wauwatosa, WI 53226
United States

Ty Carroll, MD
James Findling, MD
Bradley Javorsky, MD
Beth Lalande, MD
Steven Magill, MD, PhD
Brian Rose, MD
Joseph Shaker, MD

All persons in control of content have NO relevant financial relationships with the exception of:

Bart Clarke, MD - NPS Pharmaceuticals, Inc; Amgen, Inc.
In accordance with the ACCME® standards for Commercial Support Number 6, all in control of content disclosed any relevant financial relationships. These relationships were reviewed via the MCW conflict of interest resolution process and resolved.


A $2.50 processing fee is assessed on all registrations. 

Cancellation policy: No refunds


ACCME Accreditation Statement:
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of The Medical College of Wisconsin and The Wisconsin Endocrine Society. The Medical College of Wisconsin is accredited by the ACCME to provide continuing medical education for physicians.


AMA Credit Designation Statement:

The Medical College of Wisconsin designates this live activity for a maximum of 1.0  AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Hours of Participation for Allied Health Care Professionals
The Medical College of Wisconsin designates this activity for up to 1.0 hours of participation for continuing education for allied health professionals. 

Available Credit

  • 1.00 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 1.00 Hours of Participation
    Hours of Participation credit.


Please login or register to take this course.